Cointime

Lumen Bioscience

company

About

Lumen Bio discovers, develops, & manufactures biologic drugs and vaccine candidates for several prevalent, worldwide diseases.

  • 51 - 100

Highlights

Total Funding Amount
$33M
Funding Rounds
4
Investors
3

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.80M
Industries
Biopharma,Biotechnology,Life Science
Founded date
Apr 1, 2017
Number Of Employee
51 - 100
Operating Status
Active

Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$33M
Lumen Bioscience has raised a total of $33M in funding over 2 rounds. Their latest funding was raised on Sep 24, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 24, 2020 Grant $4M 1 U.S. Army Medical Research & Development Command — Detail
Sep 1, 2020 Series B $16M 1 — — Detail
Dec 5, 2017 Grant $1.80M 1 US Department of Energy — Detail
Dec 5, 2017 Series A $11.20M 1 Avista Development — Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Lumen Bioscience is funded by 3 investors. U.S. Army Medical Research & Development Command and US Department of Energy are the most recent investors.
Investor Name Lead Investor Funding Round
U.S. Army Medical Research & Development Command Yes Grant
US Department of Energy Yes Grant
Avista Development — Series B
Cointime
Chủ Đề
Công Ty